Table 3 Association between lymphovascular invasion and non-SLNs metastasis according to baseline characteristics
Sub-group | Lymphovascular invasion | Non-lymphovascular invasion | OR (95%CI) | Mutually adjusted | ||
|---|---|---|---|---|---|---|
Total | Metastasis | Total | Metastasis | Crude | ||
ER | ||||||
Negative | 28 | 16 | 19 | 5 | 3.7 (1.1, 13.2) | 32.9 (2.4, 453.4) |
Positive | 116 | 78 | 117 | 27 | 6.8 (3.8, 12.2) | 6.9 (3.6, 13.3) |
HER-2 | ||||||
Negative | 105 | 66 | 110 | 22 | 6.8 (3.7, 12.5) | 7.0 (3.5, 14.2) |
Positive | 38 | 28 | 25 | 9 | 5.0 (1.7, 14.8) | 11.6 (2.4, 56.3) |
Histology grading | ||||||
High | 7 | 4 | 18 | 5 | 3.5 (0.6, 21.4) | inf. (0.0, Inf) |
Low | 132 | 85 | 99 | 22 | 6.3 (3.5, 11.5) | 6.1 (3.2, 11.6) |
Ki-67 | ||||||
Low | 94 | 61 | 109 | 27 | 5.6 (3.1, 10.3) | 5.9 (2.9, 11.8) |
High | 50 | 33 | 25 | 5 | 7.8 (2.5, 24.3) | 12.4 (3.1, 49.2) |
Number of positive SLN | ||||||
> 2 | 42 | 34 | 20 | 11 | 3.5 (1.1, 11.2) | 2.6 (0.6, 11.9) |
≤ 2 | 102 | 60 | 116 | 21 | 6.5 (3.5, 12.0) | 7.8 (3.9, 15.8) |
PR | ||||||
Negative | 44 | 27 | 33 | 7 | 5.9 (2.1, 16.6) | 23.4 (4.2, 129.7) |
Positive | 100 | 67 | 103 | 25 | 6.3 (3.4, 11.7) | 6.0 (3.0, 12.0) |
Menopause | ||||||
No | 88 | 56 | 75 | 18 | 5.5 (2.8, 11.0) | 4.9 (2.3, 10.8) |
Yes | 56 | 38 | 61 | 14 | 7.1 (3.1, 16.1) | 9.6 (3.5, 26.3) |
Tumor size | ||||||
≤ 2 cm | 36 | 20 | 57 | 12 | 4.7 (1.9, 11.7) | 3.9 (1.4, 11.4) |
> 2 cm | 108 | 74 | 79 | 20 | 6.4 (3.4, 12.3) | 8.9 (4.0, 19.4) |
Age group | ||||||
≤ 50 years | 65 | 13 | 78 | 54 | 9.00 (4.15, 19.53) | 8.0 (3.2, 19.5) |
> 50 years | 71 | 19 | 66 | 40 | 4.21 (2.05, 8.66) | 4.9 (2.1, 11.3) |